0001209191-21-009487.txt : 20210210
0001209191-21-009487.hdr.sgml : 20210210
20210210210458
ACCESSION NUMBER: 0001209191-21-009487
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210208
FILED AS OF DATE: 20210210
DATE AS OF CHANGE: 20210210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Segal Lloyd Mitchell
CENTRAL INDEX KEY: 0001477123
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39335
FILM NUMBER: 21616259
MAIL ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
CITY: LAVAL
STATE: A8
ZIP: H7L 4A8
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Repare Therapeutics Inc.
CENTRAL INDEX KEY: 0001808158
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: Z4
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7210 FREDERICK-BANTING, SUITE 100
CITY: ST-LAURENT
STATE: A8
ZIP: H4S 2A1
BUSINESS PHONE: (857) 412-7018
MAIL ADDRESS:
STREET 1: 7210 FREDERICK-BANTING, SUITE 100
CITY: ST-LAURENT
STATE: A8
ZIP: H4S 2A1
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-08
0
0001808158
Repare Therapeutics Inc.
RPTX
0001477123
Segal Lloyd Mitchell
C/O REPARE THERAPEUTICS INC.
7210 FREDERICK-BANTING, SUITE 100
ST-LAURENT
A8
H4S 2A1
QUEBEC, CANADA
0
1
0
0
President and CEO
Employee Stock Option (right to buy)
36.91
2021-02-08
4
A
0
125000
0.00
A
2031-02-08
Common Stock
125000
125000
D
Twenty-five percent (25%) of the shares subject to the option shall vest on February 5, 2022, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.
/s/ Steve Forte, Attorney-in-Fact
2021-02-10